Sioulas Vasilios Obstetrician - Gynecologist

Education & Academic Qualifications

2016: Accreditation in Gynecologic Oncology, European Society of Gynaecological Oncology (ESGO)
2014-2016: International Fellowship in Gynecologic Oncology, Memorial Sloan Kettering Cancer Center (NY, USA)

2007-2012: Residency in OBGYN, 3^rd Department of Obstetrics & Gynecology, National and Kapodistrian University of Athens, Attikon Hospital

2009-2012: MSc in “High Risk Pregnancies”, Medical School, National and Kapodistrian University of Athens

2003-2008: Menopause Clinic, 2^nd Department of Obstetrics & Gynecology, National and Kapodistrian University of Athens, Aretaieio Hospital
«The effect of hormone therapy, tibolone and raloxifene on the expression of E-cadherin and VEGF in cervical epithelial cells from postmenopausal women»

2016 onwards: Obstetrician-Gynecologist, Head of the Department of Gynecologic Oncology, Member of the Gynecologic Tumor Board, MITERA Hospital
2016 onwards: Gynecologist, HYGEIA Hospital
2014-2016: International Fellowship in Gynecologic Oncology, Memorial Sloan Kettering Cancer Center (NY, USA)

2012-2014: Scientific Associate, 3^rd Department of Obstetrics & Gynecology, National and Kapodistrian University of Athens, Attikon Hospital

Clinical Interest:

Surgical treatment of gynecologic cancers
Robotic and laparoscopic surgery for benign and malignant diseases of the female genital tract
Prevention of gynecologic cancer in patients with hereditary risk or breast cancer
HPV and cervical pathology

Research interest:

2003: National and Kapodistrian University of Athens
1999: State Scholarships Foundation
1998: Laboratory of Anatomy, Medical School, National and Kapodistrian University of Athens

Considerations for Vulvar Cancer. In: Delman KA and Master V. Malignancies of the Groin: Surgical and Anatomic Consderations. 2017
Gynecologic Oncology Fellowship Training in the USA. In: European Society of Gynaecological Oncology. Textbook of Gynaecological Oncology. 3rd Edition, 2016

Fetal growth disorders. In: Salamalekis EE. The pathology of pregnancy (High-risk pregnancies). Volume 2. Athens: Mendor Editions S.A., 2011

Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy? Sioulas VD, Schiavone MB, Kadouri D, et al. Gynecol Oncol 2017;145:15-20

yH2Ax expression as a potential biomarker differentiating between low and high grade cervical squamous intraepithelial lesions (SIL) and high risk HPV related SIL. Leventakos K, Tsiodras S, Kelesidis T, Kefala M, Kottaridi C, Spathis A, Gouloumi AR, Pouliakis A, Pappas A, Sioulas V, et al. PLoS One 2017;12:e0170626
Robotically-assisted laparoscopic ovarian transposition in women with lower gastrointestinal cancer undergoing pelvic radiotherapy. Sioulas VD, Jorge S, Chern J-Y, Schiavone MB, et al. Ann Surg Oncol 2017;24:251-6

Impact of robotic platforms on surgical approach and costs in the management of morbidly obese patients with newly diagnosed uterine cancer. Leitao MM, Narain WR, Boccamazzo D, Sioulas V, et al. Ann Surg Oncol 2016;23:2192-8
The role of microRNAs in endometrial cancer. Vasilatou D, Sioulas VD, Pappa V, et al. Epigenomics 2015;7:951-9
Prevalence of Human Papillomavirus in saliva and cervix of sexually active women. Adamopoulou M, Vairaktaris E, Nkenke E, Avgoustidis D, Karakitsos P, Sioulas V, et al. Gynecol Oncol 2013;129:395-400
How and when hCG curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity. Dillon KE, Sioulas VD, Sammel MD, et al. Fertil Steril 2012;98:911-6

Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: is it safe? Sioulas VD, Gracia CR. J Assist Reprod Genet 2012;29:271-5

Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells? Sioulas VD, Politi E, Rizos D, et al. Climacteric 2012;15:181-5
E-cadherin expression in cervical epithelial cells of postmenopausal women: association with hormone therapy, tibolone and raloxifene. Sioulas V, Christodoulakos G, Lambrinoudaki I, et al. Fertil Steril 2008;89:1018-20